Titan Pharmaceuticals, Inc. (TTNP)

USD 3.6

(-1.66%)

Revenue Summary of Titan Pharmaceuticals, Inc.

  • Titan Pharmaceuticals, Inc.'s latest annual revenue in 2023 was 184 Thousand USD , up 206.67% from previous year.
  • Titan Pharmaceuticals, Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Titan Pharmaceuticals, Inc. reported a annual revenue of 60 Thousand USD in annual revenue 2022, down -96.07% from previous year.
  • Titan Pharmaceuticals, Inc. reported a annual revenue of 1.52 Million USD in annual revenue 2021, down -68.46% from previous year.
  • Titan Pharmaceuticals, Inc. reported a quarterly revenue of - USD for 2024 Q1, down -100.0% from previous quarter.
  • Titan Pharmaceuticals, Inc. reported a quarterly revenue of 98 Thousand USD for 2023 Q1, up 92.16% from previous quarter.

Annual Revenue Chart of Titan Pharmaceuticals, Inc. (2023 - 1995)

Historical Annual Revenue of Titan Pharmaceuticals, Inc. (2023 - 1995)

Year Revenue Revenue Growth
2023 184 Thousand USD 206.67%
2022 60 Thousand USD -96.07%
2021 1.52 Million USD -68.46%
2020 4.83 Million USD 33.98%
2019 3.61 Million USD -38.91%
2018 5.91 Million USD 2649.3%
2017 215 Thousand USD -98.57%
2016 15.06 Million USD 801.56%
2015 1.67 Million USD -54.17%
2014 3.64 Million USD -65.21%
2013 10.48 Million USD 47.27%
2012 7.11 Million USD 74.95%
2011 4.06 Million USD -59.69%
2010 10.09 Million USD 12675.95%
2009 79 Thousand USD 12.86%
2008 70 Thousand USD 191.67%
2007 24 Thousand USD -25.0%
2006 32 Thousand USD -64.04%
2005 89 Thousand USD 187.1%
2004 31 Thousand USD -65.17%
2003 89 Thousand USD -96.92%
2002 2.89 Million USD -36.75%
2001 4.57 Million USD 143.19%
2000 1.88 Million USD 526.67%
1999 300 Thousand USD 200.0%
1998 100 Thousand USD -99.43%
1997 17.5 Million USD 5733.33%
1996 300 Thousand USD 200.0%
1995 100 Thousand USD 0.0%

Peer Revenue Comparison of Titan Pharmaceuticals, Inc.

Name Revenue Revenue Difference
AbCellera Biologics Inc. 38.02 Million USD 99.516%
Alkermes plc 1.66 Billion USD 99.989%
Agenus Inc. 156.31 Million USD 99.882%
Aptorum Group Limited 431.37 Thousand USD 57.346%
Ardelyx, Inc. 124.45 Million USD 99.852%
Dyadic International, Inc. 2.89 Million USD 93.653%
Eton Pharmaceuticals, Inc. 31.64 Million USD 99.418%
Lantern Pharma Inc. - USD -Infinity%
Inhibikase Therapeutics, Inc. 260.5 Thousand USD 29.367%
Novavax, Inc. 983.7 Million USD 99.981%
Janux Therapeutics, Inc. 8.08 Million USD 97.724%
Pyxis Oncology, Inc. - USD -Infinity%
TransCode Therapeutics, Inc. - USD -Infinity%
Ocuphire Pharma, Inc. 19.04 Million USD 99.034%
Outlook Therapeutics, Inc. - USD -Infinity%
Madrigal Pharmaceuticals, Inc. - USD -Infinity%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
SELLAS Life Sciences Group, Inc. - USD -Infinity%
Syros Pharmaceuticals, Inc. 9.93 Million USD 98.148%
Barinthus Biotherapeutics plc 802 Thousand USD 77.057%
Windtree Therapeutics, Inc. - USD -Infinity%
Xeris Biopharma Holdings, Inc. 163.91 Million USD 99.888%
Clearside Biomedical, Inc. 8.22 Million USD 97.763%
C4 Therapeutics, Inc. 20.75 Million USD 99.114%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 99.99%
AlloVir, Inc. - USD -Infinity%
Arrowhead Pharmaceuticals, Inc. 240.73 Million USD 99.924%
VYNE Therapeutics Inc. 424 Thousand USD 56.604%
Bicycle Therapeutics plc 26.97 Million USD 99.318%
BioXcel Therapeutics, Inc. 1.38 Million USD 86.667%
ChromaDex Corporation 83.57 Million USD 99.78%
Chimerix, Inc. 324 Thousand USD 43.21%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Caribou Biosciences, Inc. 34.47 Million USD 99.466%
CRISPR Therapeutics AG 371.2 Million USD 99.95%
Precision BioSciences, Inc. 48.72 Million USD 99.622%
Fate Therapeutics, Inc. 63.53 Million USD 99.71%
Fortress Biotech, Inc. 84.51 Million USD 99.782%
Fortress Biotech, Inc. 84.51 Million USD 99.782%
HOOKIPA Pharma Inc. 20.12 Million USD 99.086%
ImmuCell Corporation 17.47 Million USD 98.947%
IDEAYA Biosciences, Inc. 23.38 Million USD 99.213%
Immix Biopharma, Inc. - USD -Infinity%
Incyte Corporation 3.69 Billion USD 99.995%
Innoviva, Inc. 310.46 Million USD 99.941%
IO Biotech, Inc. - USD -Infinity%
Jaguar Health, Inc. 9.76 Million USD 98.115%
Keros Therapeutics, Inc. 151 Thousand USD -21.854%
Ligand Pharmaceuticals Incorporated 131.31 Million USD 99.86%
ContextLogic Inc. 287 Million USD 99.936%
MiMedx Group, Inc. 321.47 Million USD 99.943%
MEI Pharma, Inc. 65.29 Million USD 99.718%
NextCure, Inc. - USD -Infinity%
Onconetix, Inc. 58.46 Thousand USD -214.718%
Oncternal Therapeutics, Inc. 785 Thousand USD 76.561%
Opthea Limited 261.85 Thousand USD 29.733%
Psyence Biomedical Ltd. - USD -Infinity%
Vaxcyte, Inc. - USD -Infinity%
PDS Biotechnology Corporation - USD -Infinity%
Precigen, Inc. 6.22 Million USD 97.044%
Pharming Group N.V. 245.31 Million USD 99.925%
Phathom Pharmaceuticals, Inc. 682 Thousand USD 73.021%
Pieris Pharmaceuticals, Inc. 42.81 Million USD 99.57%
PureTech Health plc 3.33 Million USD 94.474%
Rigel Pharmaceuticals, Inc. 116.88 Million USD 99.843%
Avidity Biosciences, Inc. 9.56 Million USD 98.075%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Sangamo Therapeutics, Inc. 176.23 Million USD 99.896%
Sol-Gel Technologies Ltd. 1.55 Million USD 88.16%
Acelyrin, Inc. - USD -Infinity%
Salarius Pharmaceuticals, Inc. - USD -Infinity%
Summit Therapeutics Inc. - USD -Infinity%
Sensei Biotherapeutics, Inc. - USD -Infinity%
Senti Biosciences, Inc. 2.56 Million USD 92.815%
Stoke Therapeutics, Inc. 8.78 Million USD 97.904%
Elevation Oncology, Inc. - USD -Infinity%
Alaunos Therapeutics, Inc. 5000.00 USD -3580.0%
Telomir Pharmaceuticals, Inc. Common Stock - USD -Infinity%
Entrada Therapeutics, Inc. 129.01 Million USD 99.857%
VistaGen Therapeutics, Inc. 1.06 Million USD 82.707%
Kintara Therapeutics, Inc. - USD -Infinity%
Wave Life Sciences Ltd. 113.3 Million USD 99.838%
Seer, Inc. 15.18 Million USD 98.788%
Verrica Pharmaceuticals Inc. 5.12 Million USD 96.409%
Aadi Bioscience, Inc. 24.35 Million USD 99.244%
ESSA Pharma Inc. - USD -Infinity%
GlycoMimetics, Inc. 10 Thousand USD -1740.0%
GT Biopharma, Inc. - USD -Infinity%
Inhibrx Biosciences, Inc. 1.8 Million USD 89.778%
Akebia Therapeutics, Inc. 194.62 Million USD 99.905%
Catalyst Pharmaceuticals, Inc. 398.2 Million USD 99.954%
Longboard Pharmaceuticals, Inc. - USD -Infinity%
Orchestra BioMed Holdings, Inc. 2.76 Million USD 93.333%
Alzamend Neuro, Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 62.83 Million USD 99.707%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 98.472%
Viracta Therapeutics, Inc. - USD -Infinity%
Rocket Pharmaceuticals, Inc. - USD -Infinity%
Aptose Biosciences Inc. - USD -Infinity%
ZyVersa Therapeutics, Inc. - USD -Infinity%
Soligenix, Inc. 839.35 Thousand USD 78.079%
Century Therapeutics, Inc. 2.23 Million USD 91.767%
Kura Oncology, Inc. - USD -Infinity%
TScan Therapeutics, Inc. 21.04 Million USD 99.126%
Intensity Therapeutics, Inc. - USD -Infinity%
Ocean Biomedical, Inc. - USD -Infinity%
CytomX Therapeutics, Inc. 101.21 Million USD 99.818%
Autolus Therapeutics plc 1.69 Million USD 89.164%
Mineralys Therapeutics, Inc. - USD -Infinity%
EyePoint Pharmaceuticals, Inc. 46.01 Million USD 99.6%
Eterna Therapeutics Inc. 68 Thousand USD -170.588%
Adaptive Biotechnologies Corporation 170.27 Million USD 99.892%
GRI Bio, Inc. 21.76 Million USD 99.155%
Xenetic Biosciences, Inc. 2.53 Million USD 92.756%
Tenaya Therapeutics, Inc. - USD -Infinity%
IGM Biosciences, Inc. 2.13 Million USD 91.362%
INmune Bio, Inc. 155 Thousand USD -18.71%
Heron Therapeutics, Inc. 127.04 Million USD 99.855%
SAB Biotherapeutics, Inc. 2.23 Million USD 91.782%
Pasithea Therapeutics Corp. - USD -Infinity%
Entero Therapeutics, Inc. - USD -Infinity%
Milestone Pharmaceuticals Inc. 1 Million USD 81.6%
X4 Pharmaceuticals, Inc. - USD -Infinity%
Atara Biotherapeutics, Inc. 8.57 Million USD 97.854%
Coherus BioSciences, Inc. 257.24 Million USD 99.928%
Verastem, Inc. - USD -Infinity%
Abeona Therapeutics Inc. 3.5 Million USD 94.743%
Pliant Therapeutics, Inc. 1.58 Million USD 88.354%
Tonix Pharmaceuticals Holding Corp. 7.76 Million USD 97.631%
Histogen Inc. 3.76 Million USD 95.118%
Aprea Therapeutics, Inc. 583.23 Thousand USD 68.452%
Surrozen, Inc. - USD -Infinity%
Organovo Holdings, Inc. 109 Thousand USD -68.807%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Ovid Therapeutics Inc. 391.69 Thousand USD 53.025%
Panbela Therapeutics, Inc. - USD -Infinity%
CASI Pharmaceuticals, Inc. 33.87 Million USD 99.457%
Cadrenal Therapeutics, Inc. Common Stock - USD -Infinity%
Centessa Pharmaceuticals plc 6.85 Million USD 97.315%
Hepion Pharmaceuticals, Inc. - USD -Infinity%
Arcturus Therapeutics Holdings Inc. 157.74 Million USD 99.883%
BioRestorative Therapies, Inc. 145.8 Thousand USD -26.2%
Apollomics, Inc. 821 Thousand USD 77.588%
Amarin Corporation plc 306.91 Million USD 99.94%
Mesoblast Limited 5.9 Million USD 96.882%
Turnstone Biologics Corp. 19.3 Million USD 99.047%
Kymera Therapeutics, Inc. 78.59 Million USD 99.766%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd - USD -Infinity%
Aurinia Pharmaceuticals Inc. 175.51 Million USD 99.895%
BriaCell Therapeutics Corp. - USD -Infinity%
Monopar Therapeutics Inc. - USD -Infinity%
Exelixis, Inc. 1.83 Billion USD 99.99%
Better Therapeutics, Inc. - USD -Infinity%
Nurix Therapeutics, Inc. 76.98 Million USD 99.761%
Apellis Pharmaceuticals, Inc. 396.59 Million USD 99.954%
NLS Pharmaceutics AG - USD -Infinity%
Dermata Therapeutics, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Gritstone bio, Inc. 1.33 Million USD 86.176%
Jasper Therapeutics, Inc. - USD -Infinity%
TNF Pharmaceuticals, Inc. - USD -Infinity%
Avid Bioservices, Inc. 139.91 Million USD 99.868%
Insmed Incorporated 305.2 Million USD 99.94%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
MediWound Ltd. 18.68 Million USD 99.015%
OmniAb, Inc. 34.16 Million USD 99.461%
Alector, Inc. 97.06 Million USD 99.81%
Seres Therapeutics, Inc. 126.32 Million USD 99.854%
Checkpoint Therapeutics, Inc. 103 Thousand USD -78.641%
Zai Lab Limited 266.71 Million USD 99.931%
Revance Therapeutics, Inc. 234.04 Million USD 99.921%
Aura Biosciences, Inc. - USD -Infinity%
Lyell Immunopharma, Inc. 130 Thousand USD -41.538%
Immunic, Inc. - USD -Infinity%
Tarsus Pharmaceuticals, Inc. 17.44 Million USD 98.945%
Veracyte, Inc. 361.05 Million USD 99.949%
InMed Pharmaceuticals Inc. 4.59 Million USD 95.998%
FibroGen, Inc. 147.75 Million USD 99.875%
SeaStar Medical Holding Corporation - USD -Infinity%
Adial Pharmaceuticals, Inc. - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 147.8 Thousand USD -24.488%
Jazz Pharmaceuticals plc 3.83 Billion USD 99.995%
Cyclacel Pharmaceuticals, Inc. 420 Thousand USD 56.19%
Amylyx Pharmaceuticals, Inc. 380.78 Million USD 99.952%
TG Therapeutics, Inc. 233.66 Million USD 99.921%
Galecto, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Fortrea Holdings Inc. 3.1 Billion USD 99.994%
KalVista Pharmaceuticals, Inc. - USD -Infinity%
Aptevo Therapeutics Inc. - USD -Infinity%
XBiotech Inc. - USD -Infinity%
Jasper Therapeutics, Inc. - USD -Infinity%
Lyra Therapeutics, Inc. 1.55 Million USD 88.19%
Foghorn Therapeutics Inc. 34.15 Million USD 99.461%
Y-mAbs Therapeutics, Inc. 84.81 Million USD 99.783%
Theravance Biopharma, Inc. 57.42 Million USD 99.68%
Ultragenyx Pharmaceutical Inc. 434.24 Million USD 99.958%
Metagenomi, Inc. Common Stock 44.75 Million USD 99.589%
Vaxxinity, Inc. - USD -Infinity%
BioCryst Pharmaceuticals, Inc. 331.41 Million USD 99.944%
Gain Therapeutics, Inc. 55.18 Thousand USD -233.454%
Cartesian Therapeutics, Inc. 26 Million USD 99.292%
NexImmune, Inc. - USD -Infinity%
Creative Medical Technology Holdings, Inc. 9000.00 USD -1944.444%
Marker Therapeutics, Inc. 3.31 Million USD 94.443%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 99.999%
Chemomab Therapeutics Ltd. - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
RAPT Therapeutics, Inc. - USD -Infinity%
Ainos, Inc. 122.11 Thousand USD -50.681%
Pluri Inc. 326 Thousand USD 43.558%
Prothena Corporation plc 91.37 Million USD 99.799%
Adaptimmune Therapeutics plc 60.28 Million USD 99.695%
Celularity Inc. 22.77 Million USD 99.192%
Rallybio Corporation - USD -Infinity%
Cue Biopharma, Inc. 5.49 Million USD 96.648%
MeiraGTx Holdings plc 14.01 Million USD 98.687%
Omeros Corporation - USD -Infinity%
Humacyte, Inc. - USD -Infinity%
Immunocore Holdings plc 249.42 Million USD 99.926%
Cocrystal Pharma, Inc. - USD -Infinity%
Cidara Therapeutics, Inc. 63.9 Million USD 99.712%
Blueprint Medicines Corporation 249.38 Million USD 99.926%
CalciMedica, Inc. - USD -Infinity%
Cabaletta Bio, Inc. - USD -Infinity%
Marinus Pharmaceuticals, Inc. 30.98 Million USD 99.406%
Scholar Rock Holding Corporation - USD -Infinity%
Sana Biotechnology, Inc. - USD -Infinity%
Pulmatrix, Inc. 7.29 Million USD 97.479%
Elicio Therapeutics, Inc. - USD -Infinity%
Vigil Neuroscience, Inc. - USD -Infinity%
Intellia Therapeutics, Inc. 36.27 Million USD 99.493%
Adlai Nortye Ltd. American Depositary Shares 4.99 Million USD 96.317%
Cytokinetics, Incorporated 7.53 Million USD 97.556%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Nutriband Inc. 2.08 Million USD 91.176%
Protara Therapeutics, Inc. - USD -Infinity%
Vor Biopharma Inc. - USD -Infinity%
Roivant Sciences Ltd. 124.79 Million USD 99.853%
Evogene Ltd. 5.64 Million USD 96.738%
ProKidney Corp. - USD -Infinity%
Applied Therapeutics, Inc. 9.99 Million USD 98.159%
Hoth Therapeutics, Inc. - USD -Infinity%
BridgeBio Pharma, Inc. 9.3 Million USD 98.022%
CorMedix Inc. - USD -Infinity%
BioLineRx Ltd. 4.8 Million USD 96.167%
Tango Therapeutics, Inc. 36.52 Million USD 99.496%
Galectin Therapeutics Inc. - USD -Infinity%
Atai Life Sciences N.V. 314 Thousand USD 41.401%
Renovaro Biosciences Inc. - USD -Infinity%
Aerovate Therapeutics, Inc. - USD -Infinity%
Zentalis Pharmaceuticals, Inc. - USD -Infinity%
Sagimet Biosciences Inc. 2 Million USD 90.8%
MediciNova, Inc. 1 Million USD 81.6%
Praxis Precision Medicines, Inc. 2.44 Million USD 92.481%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -978.23%
GeoVax Labs, Inc. - USD -Infinity%
Axsome Therapeutics, Inc. 270.6 Million USD 99.932%
Biomea Fusion, Inc. - USD -Infinity%
PTC Therapeutics, Inc. 937.82 Million USD 99.98%
Mereo BioPharma Group plc 10 Million USD 98.16%
Cullinan Oncology, Inc. - USD -Infinity%
Syndax Pharmaceuticals, Inc. - USD -Infinity%
Absci Corporation 5.71 Million USD 96.782%
NRx Pharmaceuticals, Inc. - USD -Infinity%
4D Molecular Therapeutics, Inc. 20.72 Million USD 99.112%
Dyne Therapeutics, Inc. - USD -Infinity%
Kiniksa Pharmaceuticals, Ltd. 270.25 Million USD 99.932%
Ventyx Biosciences, Inc. - USD -Infinity%
Allakos Inc. - USD -Infinity%
Imunon, Inc. - USD -Infinity%
Fulcrum Therapeutics, Inc. 2.8 Million USD 93.44%
Corcept Therapeutics Incorporated 482.37 Million USD 99.962%
BioAtla, Inc. - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
Bio-Path Holdings, Inc. - USD -Infinity%
Allogene Therapeutics, Inc. 95 Thousand USD -93.684%
Larimar Therapeutics, Inc. - USD -Infinity%
XOMA Corporation 4.75 Million USD 96.133%
Kezar Life Sciences, Inc. 7 Million USD 97.371%
Cara Therapeutics, Inc. 20.96 Million USD 99.122%
aTyr Pharma, Inc. 353 Thousand USD 47.875%
Aligos Therapeutics, Inc. 15.52 Million USD 98.815%
Akero Therapeutics, Inc. - USD -Infinity%
Viridian Therapeutics, Inc. 314 Thousand USD 41.401%
Eliem Therapeutics, Inc. - USD -Infinity%
EyeGate Pharmaceuticals, Inc. 12.05 Thousand USD -1425.831%
Akari Therapeutics, Plc - USD -Infinity%
Tevogen Bio Holdings Inc. - USD -Infinity%
Halozyme Therapeutics, Inc. 829.25 Million USD 99.978%
Lexaria Bioscience Corp. 226.2 Thousand USD 18.659%
UroGen Pharma Ltd. 82.71 Million USD 99.778%
Sutro Biopharma, Inc. 153.73 Million USD 99.88%
ZIVO Bioscience, Inc. 27.65 Thousand USD -565.461%
Orgenesis Inc. 530 Thousand USD 65.283%
Entera Bio Ltd. - USD -Infinity%
GH Research PLC - USD -Infinity%
Lisata Therapeutics, Inc. - USD -Infinity%
Reneo Pharmaceuticals, Inc. - USD -Infinity%
Xencor, Inc. 168.33 Million USD 99.891%
60 Degrees Pharmaceuticals, Inc. 253.57 Thousand USD 27.437%
Replimune Group, Inc. - USD -Infinity%
Coeptis Therapeutics Holdings, Inc. - USD -Infinity%
Vanda Pharmaceuticals Inc. 192.64 Million USD 99.904%
Lexaria Bioscience Corp. 226.2 Thousand USD 18.659%
Portage Biotech Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -978.23%
Olema Pharmaceuticals, Inc. - USD -Infinity%
OncoCyte Corporation 1.5 Million USD 87.758%
Qualigen Therapeutics, Inc. 5.2 Million USD 96.465%
Processa Pharmaceuticals, Inc. - USD -Infinity%
Purple Biotech Ltd. - USD -Infinity%
CollPlant Biotechnologies Ltd. 10.95 Million USD 98.321%
scPharmaceuticals Inc. 13.59 Million USD 98.646%
ProMIS Neurosciences, Inc. - USD -Infinity%
HilleVax, Inc. - USD -Infinity%
NeuroSense Therapeutics Ltd. - USD -Infinity%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
Neumora Therapeutics, Inc. Common Stock - USD -Infinity%
Atossa Therapeutics, Inc. - USD -Infinity%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Savara Inc. - USD -Infinity%
Curis, Inc. 10.02 Million USD 98.164%
Daré Bioscience, Inc. 2.8 Million USD 93.447%
Carmell Therapeutics Corporation - USD -Infinity%
Achieve Life Sciences, Inc. - USD -Infinity%
BeiGene, Ltd. 2.45 Billion USD 99.993%
Kiromic BioPharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. Warrant 11.58 Million USD 98.411%
Protagonist Therapeutics, Inc. 60 Million USD 99.693%
Erasca, Inc. - USD -Infinity%
bluebird bio, Inc. 29.49 Million USD 99.376%
Protagenic Therapeutics, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 99.992%
DBV Technologies S.A. 15.72 Million USD 98.83%
Protagenic Therapeutics, Inc. - USD -Infinity%
Moderna, Inc. 6.84 Billion USD 99.997%
Vincerx Pharma, Inc. - USD -Infinity%
Fresh Tracks Therapeutics, Inc. 8 Million USD 97.702%
Molecular Templates, Inc. 57.3 Million USD 99.679%
Acrivon Therapeutics, Inc. Common Stock - USD -Infinity%
Travere Therapeutics, Inc. 145.23 Million USD 99.873%
Monte Rosa Therapeutics, Inc. - USD -Infinity%
Spruce Biosciences, Inc. 10.08 Million USD 98.176%
Celldex Therapeutics, Inc. 6.88 Million USD 97.327%
Cogent Biosciences, Inc. - USD -Infinity%
MacroGenics, Inc. 58.74 Million USD 99.687%
RenovoRx, Inc. - USD -Infinity%
Adicet Bio, Inc. - USD -Infinity%
Prime Medicine, Inc. - USD -Infinity%
Aditxt, Inc. 645.17 Thousand USD 71.481%
Adagene Inc. 18.11 Million USD 98.984%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 82.994%
Maravai LifeSciences Holdings, Inc. 288.94 Million USD 99.936%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Voyager Therapeutics, Inc. 250 Million USD 99.926%
SciSparc Ltd. 2.87 Million USD 93.609%
Vericel Corporation 197.51 Million USD 99.907%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. - USD -Infinity%
Generation Bio Co. 5.9 Million USD 96.883%
Astria Therapeutics, Inc. - USD -Infinity%
Black Diamond Therapeutics, Inc. - USD -Infinity%
Arcutis Biotherapeutics, Inc. 59.6 Million USD 99.691%
Invivyd, Inc. - USD -Infinity%
Relay Therapeutics, Inc. 25.54 Million USD 99.28%
Quoin Pharmaceuticals, Ltd. - USD -Infinity%
Spero Therapeutics, Inc. 96.73 Million USD 99.81%
Artelo Biosciences, Inc. - USD -Infinity%
2seventy bio, Inc. 100.38 Million USD 99.817%
ADMA Biologics, Inc. 258.21 Million USD 99.929%
Clene Inc. 654 Thousand USD 71.865%
Capricor Therapeutics, Inc. 25.17 Million USD 99.269%
Boundless Bio, Inc. Common Stock - USD -Infinity%
GeoVax Labs, Inc. - USD -Infinity%
Recursion Pharmaceuticals, Inc. 44.57 Million USD 99.587%
Citius Pharmaceuticals, Inc. - USD -Infinity%
Contineum Therapeutics, Inc. Class A Common Stock 50 Million USD 99.632%
Relmada Therapeutics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. 107 Thousand USD -71.963%
ALX Oncology Holdings Inc. - USD -Infinity%
Vir Biotechnology, Inc. 86.18 Million USD 99.786%
Evaxion Biotech A/S 73.11 Thousand USD -151.669%
Ocular Therapeutix, Inc. 58.44 Million USD 99.685%
Verve Therapeutics, Inc. 11.75 Million USD 98.435%
Trevena, Inc. 3.12 Million USD 94.112%
Surrozen, Inc. - USD -Infinity%
Tyra Biosciences, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Galmed Pharmaceuticals Ltd. - USD -Infinity%
Unity Biotechnology, Inc. - USD -Infinity%
Tenax Therapeutics, Inc. - USD -Infinity%
Terns Pharmaceuticals, Inc. - USD -Infinity%
ACADIA Pharmaceuticals Inc. 726.43 Million USD 99.975%
Connect Biopharma Holdings Limited - USD -Infinity%
Clearmind Medicine Inc. - USD -Infinity%
Kronos Bio, Inc. 6.28 Million USD 97.074%
Bolt Biotherapeutics, Inc. 7.87 Million USD 97.664%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Viking Therapeutics, Inc. - USD -Infinity%
Statera Biopharma, Inc. - USD -Infinity%
ImmunityBio, Inc. 622 Thousand USD 70.418%
Korro Bio, Inc. - USD -Infinity%
Kineta, Inc. 5.44 Million USD 96.619%
BioVie Inc. - USD -Infinity%
Codexis, Inc. 70.14 Million USD 99.738%
Celularity Inc. 22.77 Million USD 99.192%
Crinetics Pharmaceuticals, Inc. 4.01 Million USD 95.415%
Celcuity Inc. - USD -Infinity%
Virax Biolabs Group Limited 156.41 Thousand USD -17.633%
Cibus, Inc. 1.81 Million USD 89.873%
Eledon Pharmaceuticals, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
IN8bio, Inc. - USD -Infinity%
Kodiak Sciences Inc. - USD -Infinity%
Annexon, Inc. - USD -Infinity%
Adverum Biotechnologies, Inc. 3.6 Million USD 94.889%
Assembly Biosciences, Inc. 7.16 Million USD 97.431%
Avalo Therapeutics, Inc. 1.92 Million USD 90.437%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 99.977%
Eyenovia, Inc. 3787.00 USD -4758.727%
Puma Biotechnology, Inc. 235.63 Million USD 99.922%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Xilio Therapeutics, Inc. - USD -Infinity%
Arcellx, Inc. 110.31 Million USD 99.833%
Cardiff Oncology, Inc. 488 Thousand USD 62.295%
Enanta Pharmaceuticals, Inc. 79.2 Million USD 99.768%
Regulus Therapeutics Inc. - USD -Infinity%
Moolec Science SA 905.04 Thousand USD 79.67%
Acumen Pharmaceuticals, Inc. - USD -Infinity%
Geron Corporation 237 Thousand USD 22.363%
LAVA Therapeutics N.V. 6.76 Million USD 97.282%
Royalty Pharma plc 2.35 Billion USD 99.992%
Atea Pharmaceuticals, Inc. - USD -Infinity%
Greenwich LifeSciences, Inc. - USD -Infinity%
TFF Pharmaceuticals, Inc. 733.87 Thousand USD 74.927%
Mersana Therapeutics, Inc. 36.85 Million USD 99.501%
Humacyte, Inc. - USD -Infinity%
Structure Therapeutics Inc. - USD -Infinity%
89bio, Inc. - USD -Infinity%
PMV Pharmaceuticals, Inc. - USD -Infinity%
Avenue Therapeutics, Inc. - USD -Infinity%
Genelux Corporation 170 Thousand USD -8.235%
Trevi Therapeutics, Inc. - USD -Infinity%
Lexicon Pharmaceuticals, Inc. 1.2 Million USD 84.718%
Notable Labs, Ltd. 310 Thousand USD 40.645%
Liquidia Corporation 17.48 Million USD 98.948%
Mustang Bio, Inc. - USD -Infinity%
Immunovant, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 82.994%
Arbutus Biopharma Corporation 18.14 Million USD 98.986%
DiaMedica Therapeutics Inc. - USD -Infinity%
Vera Therapeutics, Inc. 1.86 Million USD 90.118%
Acasti Pharma Inc. - USD -Infinity%
MiNK Therapeutics, Inc. - USD -Infinity%
Pasithea Therapeutics Corp. - USD -Infinity%
Xenon Pharmaceuticals Inc. - USD -Infinity%
Elevai Labs, Inc. Common Stock 1.71 Million USD 89.256%
NeuroBo Pharmaceuticals, Inc. - USD -Infinity%
Tempest Therapeutics, Inc. - USD -Infinity%
Soleno Therapeutics, Inc. - USD -Infinity%
PepGen Inc. - USD -Infinity%
Moleculin Biotech, Inc. - USD -Infinity%
United Therapeutics Corporation 2.32 Billion USD 99.992%
Nuvectis Pharma, Inc. - USD -Infinity%
Solid Biosciences Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Immuneering Corporation - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. 72.1 Thousand USD -155.194%
Belite Bio, Inc - USD -Infinity%
XOMA Corporation 4.75 Million USD 96.133%
ARS Pharmaceuticals, Inc. 30 Thousand USD -513.333%
Bionomics Limited - USD -Infinity%
Apogee Therapeutics, Inc. - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
uniQure N.V. 15.84 Million USD 98.839%
Cassava Sciences, Inc. - USD -Infinity%
Estrella Immunopharma, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 64.7 Million USD 99.716%
Forte Biosciences, Inc. - USD -Infinity%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
Enlivex Therapeutics Ltd. - USD -Infinity%
Conduit Pharmaceuticals Inc. - USD -Infinity%
SeaStar Medical Holding Corporation - USD -Infinity%
FibroBiologics, Inc. Common Stock - USD -Infinity%
Altimmune, Inc. 426 Thousand USD 56.808%
Amicus Therapeutics, Inc. 399.35 Million USD 99.954%
Alpha Tau Medical Ltd. - USD -Infinity%
Compugen Ltd. 33.45 Million USD 99.45%
Peak Bio, Inc. 367.87 Thousand USD 49.983%
Zevra Therapeutics, Inc. 27.46 Million USD 99.33%
Benitec Biopharma Inc. 216 Thousand USD 14.815%
Spyre Therapeutics, Inc. 886 Thousand USD 79.233%
NKGen Biotech, Inc. Common Stock - USD -Infinity%
Zura Bio Limited - USD -Infinity%
PolyPid Ltd. - USD -Infinity%
Aileron Therapeutics, Inc. - USD -Infinity%
NKGen Biotech, Inc. Warrants - USD -Infinity%
Instil Bio, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.985%
Immunome, Inc. 14.01 Million USD 98.687%
Compass Therapeutics, Inc. - USD -Infinity%
Verona Pharma plc - USD -Infinity%
enGene Holdings Inc. Warrants - USD -Infinity%
Shattuck Labs, Inc. 1.65 Million USD 88.896%
CervoMed Inc. 7.14 Million USD 97.425%
LENZ Therapeutics, Inc. - USD -Infinity%
Plus Therapeutics, Inc. 4.91 Million USD 96.255%
Dianthus Therapeutics, Inc. 2.82 Million USD 93.489%
Moolec Science SA 905.04 Thousand USD 79.67%
Enveric Biosciences, Inc. - USD -Infinity%
Inovio Pharmaceuticals, Inc. 832.01 Thousand USD 77.885%
AnaptysBio, Inc. 17.15 Million USD 98.928%
Design Therapeutics, Inc. - USD -Infinity%
Leap Therapeutics, Inc. - USD -Infinity%
NeurAxis, Inc. 2.46 Million USD 92.52%
Seelos Therapeutics, Inc. 2.2 Million USD 91.648%
Lumos Pharma, Inc. 2.05 Million USD 91.029%
Achilles Therapeutics plc - USD -Infinity%
enGene Holdings Inc. Common Stock - USD -Infinity%
180 Life Sciences Corp. - USD -Infinity%
Opiant Pharmaceuticals, Inc. 40.72 Million USD 99.548%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Nutriband Inc. 2.08 Million USD 91.176%
ORIC Pharmaceuticals, Inc. - USD -Infinity%
CG Oncology, Inc. Common stock 204 Thousand USD 9.804%
Fractyl Health, Inc. Common Stock 120 Thousand USD -53.333%
Rani Therapeutics Holdings, Inc. - USD -Infinity%
MoonLake Immunotherapeutics - USD -Infinity%
Palisade Bio, Inc. 250 Thousand USD 26.4%
Tourmaline Bio, Inc. - USD -Infinity%
Beam Therapeutics Inc. 377.7 Million USD 99.951%
Neurogene Inc. - USD -Infinity%
Mirum Pharmaceuticals, Inc. 186.37 Million USD 99.901%
AEON Biopharma, Inc. - USD -Infinity%
CARGO Therapeutics, Inc. Common Stock - USD -Infinity%
Sesen Bio, Inc. 40 Million USD 99.54%
Enliven Therapeutics, Inc. - USD -Infinity%
Kiora Pharmaceuticals, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 1.18 Million USD 84.525%
Taysha Gene Therapies, Inc. 15.45 Million USD 98.809%
Athira Pharma, Inc. - USD -Infinity%
Vaccinex, Inc. 570 Thousand USD 67.719%
HCW Biologics Inc. 2.84 Million USD 93.525%
XOMA Corporation 4.75 Million USD 96.133%
Nektar Therapeutics 90.12 Million USD 99.796%
Arvinas, Inc. 78.5 Million USD 99.766%
Tevogen Bio Holdings Inc. - USD -Infinity%
Merus N.V. 43.94 Million USD 99.581%
Omega Therapeutics, Inc. 3.09 Million USD 94.053%
Quince Therapeutics, Inc. - USD -Infinity%
Rezolute, Inc. - USD -Infinity%
Clene Inc. 654 Thousand USD 71.865%
Indaptus Therapeutics, Inc. - USD -Infinity%
BeyondSpring Inc. 1.75 Million USD 89.492%
Synlogic, Inc. 3.37 Million USD 94.542%
Allarity Therapeutics, Inc. - USD -Infinity%
Phio Pharmaceuticals Corp. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD 49.983%
Werewolf Therapeutics, Inc. 19.94 Million USD 99.077%
Krystal Biotech, Inc. 50.69 Million USD 99.637%
Karyopharm Therapeutics Inc. 146.03 Million USD 99.874%
SpringWorks Therapeutics, Inc. 5.44 Million USD 96.622%
Lipella Pharmaceuticals Inc. 449.61 Thousand USD 59.076%
MannKind Corporation 198.96 Million USD 99.908%
Ikena Oncology, Inc. 9.16 Million USD 97.991%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 113.45 Million USD 99.838%
Gossamer Bio, Inc. - USD -Infinity%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Legend Biotech Corporation 285.14 Million USD 99.935%
Mural Oncology plc - USD -Infinity%
Biora Therapeutics, Inc. 4000.00 USD -4500.0%
PaxMedica, Inc. Common Stock - USD -Infinity%
Disc Medicine, Inc. - USD -Infinity%
Champions Oncology, Inc. 50.15 Million USD 99.633%
REGENXBIO Inc. 90.24 Million USD 99.796%
Ensysce Biosciences, Inc. 2.23 Million USD 91.751%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. - USD -Infinity%
Edgewise Therapeutics, Inc. - USD -Infinity%
Vaxart, Inc. 7.37 Million USD 97.506%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. - USD -Infinity%
Cellectis S.A. 755 Thousand USD 75.629%
Longeveron Inc. 709 Thousand USD 74.048%
Repare Therapeutics Inc. 51.13 Million USD 99.64%
Sarepta Therapeutics, Inc. 1.24 Billion USD 99.985%
Inozyme Pharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. 11.58 Million USD 98.411%
Nymox Pharmaceutical Corporation - USD -Infinity%
Third Harmonic Bio, Inc. - USD -Infinity%
ArriVent BioPharma, Inc. Common Stock - USD -Infinity%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 210 Thousand USD 12.381%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 99.998%
Denali Therapeutics Inc. 330.53 Million USD 99.944%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 16.29 Million USD 98.871%
Corvus Pharmaceuticals, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Passage Bio, Inc. - USD -Infinity%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. - USD -Infinity%
Day One Biopharmaceuticals, Inc. - USD -Infinity%
Oramed Pharmaceuticals Inc. 2.7 Million USD 93.193%
Scinai Immunotherapeutics Ltd. - USD -Infinity%
Rhythm Pharmaceuticals, Inc. 77.42 Million USD 99.762%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 152.43 Thousand USD -20.711%
Carisma Therapeutics, Inc. 14.91 Million USD 98.767%
Unicycive Therapeutics, Inc. 675 Thousand USD 72.741%
OmniAb, Inc. 34.16 Million USD 99.461%
Anew Medical, Inc. - USD -Infinity%
Fennec Pharmaceuticals Inc. 21.25 Million USD 99.134%
Lipocine Inc. -2.85 Million USD 106.454%
Lexeo Therapeutics, Inc. Common Stock - USD -Infinity%
Nautilus Biotechnology, Inc. - USD -Infinity%
SAB Biotherapeutics, Inc. 2.23 Million USD 91.782%
G1 Therapeutics, Inc. 82.51 Million USD 99.777%
Bellerophon Therapeutics, Inc. - USD -Infinity%
Sage Therapeutics, Inc. 86.45 Million USD 99.787%
Ocugen, Inc. 6.03 Million USD 96.952%
Mind Medicine (MindMed) Inc. - USD -Infinity%
Q32 Bio Inc. 1.15 Million USD 84.083%
Brainstorm Cell Therapeutics Inc. - USD -Infinity%
Alumis Inc. Common Stock - USD -Infinity%
Equillium, Inc. 36.08 Million USD 99.49%
Kyverna Therapeutics, Inc. - USD -Infinity%
Coya Therapeutics, Inc. 6 Million USD 96.934%
CNS Pharmaceuticals, Inc. - USD -Infinity%
Galera Therapeutics, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD 70.937%
Dominari Holdings Inc. 2.03 Million USD 90.976%
Edesa Biotech, Inc. - USD -Infinity%
vTv Therapeutics Inc. - USD -Infinity%
Bio-Techne Corporation 1.15 Billion USD 99.984%
Agios Pharmaceuticals, Inc. 26.82 Million USD 99.314%
Harmony Biosciences Holdings, Inc. 582.02 Million USD 99.968%
Prelude Therapeutics Incorporated - USD -Infinity%
Candel Therapeutics, Inc. - USD -Infinity%
iTeos Therapeutics, Inc. 12.59 Million USD 98.539%
Nkarta, Inc. - USD -Infinity%
BioCardia, Inc. 477 Thousand USD 61.426%
Iterum Therapeutics plc - USD -Infinity%